U.S. Demands Ebola Quarantine Camp in Kenya—With Zero Ebola Cases
Kenya’s High Court has ordered the temporary closure of a U.S.-run Ebola quarantine center, warning it would expose the public to unacceptable risks—despite the country reporting zero confirmed Ebola cases from the current outbreak. [170750]
The facility, demanded by the United States, was shut down in May after the court ruled that the quarantine camp posed a threat to local public health. Kenya has not recorded a single case of Ebola from the ongoing outbreak, raising questions about the necessity and timing of the U.S. demand. [170750]
Critics argue that similar measures would not be accepted in Western nations without clear evidence of a local threat. The court’s order highlights growing tension between Kenya’s public health concerns and U.S. security protocols. The facility remains closed pending further legal review. [170750]
This is not the first time U.S. health aid to African nations has come under scrutiny. A new report by Human Rights Watch accuses Washington of conditioning critical health assistance on broad access to health information systems, disease samples, and the right to monitor compliance. [169239] The report, noted by the Liberian Observer, places Liberia at the center of a growing debate over "data sovereignty"—who controls a country’s medical data and biological samples. [169239]
HRW argues that the terms of U.S. aid threaten the independence of local health systems. The United States provides billions of dollars for HIV/AIDS, malaria, and pandemic preparedness, but in return requires partner nations to share patient data and pathogen samples, and to allow U.S. oversight of their health programs. [169239] Critics worry this creates an imbalance, leaving African nations at risk of losing control over their own health information. [169239]
Meanwhile, South Africa last week launched a new six-monthly injection that experts call the most promising HIV prevention tool in years. But the country may struggle to deliver it because much of the infrastructure that made HIV prevention services accessible to high-risk groups has been dismantled over the past year due to cuts to U.S. aid. [169999] The new drug, lenacapavir, offers a breakthrough: a single injection every six months instead of daily pills. Yet the trusted clinics, community health workers, and outreach programs built and funded largely by U.S. aid programs have been decimated. [169999] Health officials now ask: How can we deliver this new tool to those who need it most? [169999]